NHS

Views & Analysis

Rare disease, repurposing and the role of AI

AI is having a productive time in pharma and healthcare

Two years ago the use of AI in pharma and healthcare looked to be quickly heading for what Gartner’s Hype Cycle model would term the Plateau of Productivity.

News

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.

News

Enhertu cleared for NHS use via Cancer Drugs Fund

NICE has recommended the use of AstraZeneca and Daiichi Sankyo's Enhertu in draft guidance, the first time the drug has been commissioned in any European country.

News

Apple, Google block NHS contact tracing app update on privac...

A scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something prohibited by Apple and Google, which developed some of the code it uses.

News

Wales forms authority to drive digital health in NHS

A new organisation dedicated to increasing the use of digital health in the NHS in Wales has come into being, 18 months after the move was first unveiled by the Welsh government. <

News

NICE backs Sobi's Kineret for rare inflammatory disease

The UK's cost-effectiveness agency NICE has recommended that Sobi's Kineret can be used to treat NHS patients with Still's disease, a rare form of arthritis affecting children and adults.

AI is having a productive time in pharma and healthcare

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Enhertu cleared for NHS use via Cancer Drugs Fund

Apple, Google block NHS contact tracing app update on privac...

Wales forms authority to drive digital health in NHS

NICE backs Sobi's Kineret for rare inflammatory disease

Euro VCs team up to invigorate life sciences ecosystem

How to meet your physicians where they are online

NHS

Editor's Picks